Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

GSK plans to submit to the US Food and Drug Administration (FDA) for regulatory approval of tebipenem HBr by the end of 2025.

There are a lot of reasons why Tottenham Hotspur, despite a wretched Premier League campaign, roared back to win the Europa ...

The English defender has had a great season with the Spurs, and his leadership on the field has not gone unnoticed. Tottenham ...

Cristian Romero has been linked with a move away from Tottenham Hotspur in recent weeks, and Atletico Madrid are hoping to ...

Amid transfer market rumors and the anticipation of the Club World Cup, Cristian "Cuti" Romero has once again become a talking point. The Argentine defender, a key player for Tottenham, has hinted at ...

Sky Sports understands that Atletico Madrid are ready to make an approach to sign Cuti Romero this summer, and that they ...

GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...

Europa League Final not only crowned a new champion—it also delivered a fiery showdown between two tough defenders: Cristian ...

Tottenham emerged victorious at San Mamés in the Europa League final not just because of Manchester United’s disjointed ...

In a second piece of good news in the development of new antimicrobials this week, GSK has said it will file its oral ...